Sunshine Act Meeting

---
identifier: "/us/fr/00-15519"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Sunshine Act Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "00-15519"
section_name: "Sunshine Act Meeting"
positive_law: false
currency: "2000-06-19"
last_updated: "2000-06-19"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Consumer Product Safety Commission"
document_number: "00-15519"
document_type: "notice"
publication_date: "2000-06-19"
agencies:
  - "Consumer Product Safety Commission"
fr_citation: "65 FR 37963"
fr_volume: 65
---


#  Sunshine Act Meeting

**AGENCY:**

U.S. Consumer Product Safety Commission, Washington, DC 20207.

**TIME AND DATE:**

Friday, June 23, 2000, 10:00 a.m.

**LOCATION:**

Room 420, East West Towers, 4330 East West Highway, Bethesda, Maryland.

**STATUS:**

Open to the Public.

**MATTER TO BE CONSIDERED:**

**Oral Drugs Switched From Prescription to Over the Counter (OTC) Status**

The Commission will consider the staff's recommendation to propose that child-resistant packaging requirements for oral prescription drugs continue when such drugs are granted over-the-counter (OTC) status by the Food and Drug Administration.

For a recorded message containing the latest agenda information, call (301) 504-0709.

**CONTACT PERSON FOR ADDITIONAL INFORMATION:**

Sadye E. Dunn, Office of the Secretary, 4330 East West Highway, Bethesda, MD 20207 (301) 504-0800.

Dated: June 15, 2000.

Sadye E. Dunn,

Secretary.